Ustekinumab Active Not Recruiting Phase 3 Trials for Ulcerative Colitis / Inflammatory Bowel Diseases (IBD)

IndicationsStatusPurposePhase
Active Not RecruitingNot Available3
clinicaltrials.gov IdentifierTitleDrugs
NCT02407236A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis